Biopsy-proven histologic scores

Clinical trials for Biopsy-proven histologic scores explained in plain language.

Never miss a new study

Get alerted when new Biopsy-proven histologic scores trials appear

Sign up with your email to follow new studies for Biopsy-proven histologic scores, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 1

New hope for kidney transplant patients facing rejection

Disease control Ongoing

This study tests a new drug called ALXN2030 in 45 adults who have had a kidney transplant and are experiencing antibody-mediated rejection (AMR). The goal is to see if the drug can help resolve signs of rejection seen on a kidney biopsy after one year of treatment. Participants w…

Matched conditions: BIOPSY-PROVEN HISTOLOGIC SCORES

Phase 2 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control

Last updated Aug 13, 2026 00:00 UTC

Biopsy-proven histologic scores

Get alerted when new Biopsy-proven histologic scores trials appear

New hope for kidney transplant patients facing rejection